Overview

Efficacy and Safety Evaluation of BZ371B in ARDS Patients

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety, tolerability and efficacy of BZ371B in intubated patients with severe Acute Respiratory Distress Syndrome.
Phase:
Early Phase 1
Details
Lead Sponsor:
Biozeus Biopharmaceutical S.A.
Collaborator:
InCor Heart Institute